Black Hawk Acquisition Corp and Vesicor Therapeutics Enter Forward Purchase Agreement with Meteora for Up to 1.35M Shares; Company To Domesticate As A Delaware Corporation And Change Name To Vesicor Therapeutics Holdings; Co To Pay Meteora Final Redemption Price Less $0.75 Per Backstop Investor Share; Vesicor Therapeutics Holdings May Sell Up To $200M Of Common Stock To Meteora Over 36 Months
BBenzingaBenzinga Newsdesk
On September 22, 2026, Black Hawk Acquisition Corporation, a Cayman Islands exempted company ("BKHA" or the "Company"), and Vesicor Therapeutics, Inc., a California corporation ("Vesicor"),
On October 13, 2026, Black Hawk Acquisition Corporation (the "Company") held an extraordinary general meeting of Shareholders (the "Extraordinary General Meeting"). The record date for shareholders